Drug profile · INN
diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)
PRIMAVAX
diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed) (PRIMAVAX) is an FDA-listed pharmaceutical active ingredient.
EMA: withdrawn Antiinfectives for systemic use (J07) J07CA
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed) (PRIMAVAX) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)
Brand PRIMAVAX
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07CA
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)?
diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed) (PRIMAVAX) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)?
PRIMAVAX is a marketed brand name for diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.